全文获取类型
收费全文 | 31433篇 |
免费 | 2074篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 349篇 |
儿科学 | 849篇 |
妇产科学 | 813篇 |
基础医学 | 5316篇 |
口腔科学 | 564篇 |
临床医学 | 2876篇 |
内科学 | 6091篇 |
皮肤病学 | 875篇 |
神经病学 | 3432篇 |
特种医学 | 1449篇 |
外国民族医学 | 8篇 |
外科学 | 4004篇 |
综合类 | 212篇 |
一般理论 | 17篇 |
预防医学 | 1950篇 |
眼科学 | 675篇 |
药学 | 2093篇 |
中国医学 | 77篇 |
肿瘤学 | 1973篇 |
出版年
2021年 | 489篇 |
2020年 | 395篇 |
2019年 | 543篇 |
2018年 | 668篇 |
2017年 | 493篇 |
2016年 | 698篇 |
2015年 | 721篇 |
2014年 | 904篇 |
2013年 | 1126篇 |
2012年 | 1770篇 |
2011年 | 1860篇 |
2010年 | 981篇 |
2009年 | 978篇 |
2008年 | 1508篇 |
2007年 | 1622篇 |
2006年 | 1587篇 |
2005年 | 1571篇 |
2004年 | 1469篇 |
2003年 | 1353篇 |
2002年 | 1247篇 |
2001年 | 858篇 |
2000年 | 761篇 |
1999年 | 721篇 |
1998年 | 332篇 |
1997年 | 257篇 |
1996年 | 218篇 |
1995年 | 244篇 |
1994年 | 199篇 |
1993年 | 200篇 |
1992年 | 407篇 |
1991年 | 393篇 |
1990年 | 422篇 |
1989年 | 386篇 |
1988年 | 347篇 |
1987年 | 392篇 |
1986年 | 354篇 |
1985年 | 345篇 |
1984年 | 260篇 |
1983年 | 214篇 |
1979年 | 259篇 |
1978年 | 204篇 |
1977年 | 181篇 |
1976年 | 152篇 |
1975年 | 167篇 |
1974年 | 186篇 |
1973年 | 184篇 |
1972年 | 216篇 |
1971年 | 190篇 |
1969年 | 170篇 |
1967年 | 171篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Boffa Joseph W. Tock Jamie L. Morabito Danielle M. Schmidt Norman B. 《Cognitive therapy and research》2022,46(5):1016-1029
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study... 相似文献
2.
3.
Vogt Lina Schmidt Michelle Klasen Martin Bickenbach Johannes Marx Gernot Sopka Saša 《Der Anaesthesist》2022,71(1):21-29
Die Anaesthesiologie - Die COVID-19-Pandemie hat das deutsche Gesundheitssystem vor enorme Herausforderungen gestellt und den Bedarf an Strategien zu Rekrutierung, Schulung und Einsatzplanung von... 相似文献
4.
Lukas Hechelhammer Gautier Müllhaupt Livio Mordasini Stefan Markart Sabine Güsewell Patrick Betschart Hans-Peter Schmid Daniel S. Engeler Dominik Abt 《Journal of vascular and interventional radiology : JVIR》2019,30(2):217-224
Purpose
To assess the frequency and potential predictors of prostatic central gland tissue detachment (CGD), an enucleation-like reaction that sporadically occurred in a randomized controlled trial assessing efficacy and safety of prostatic artery embolization (PAE).Materials and Methods
Trial data were analyzed to identify patients with CGD after PAE. Clinical parameters, MR imaging findings, technical details of PAE, and periinterventional data were compared between patients with and without CGD to identify parameters for prediction, induction, or early detection of CGD after PAE.Results
CGD occurred after PAE in 3 of 48 patients (6.3%); these cases had good functional outcomes, but CGD was associated with increased risk of ejaculatory dysfunction and occurrence of complications. Frequency of preoperative transurethral bladder catheterization (100% vs 13.3%; P = .005), central gland index (mean ± standard deviation, 0.86 ± 0.02 vs 0.69 ± 0.14; P < .001), amount of particles applied (1.93 mL ± 0.12 vs 0.96 mL ± 0.36; P < .001), maximum early postoperative pain score (7.33 ± 2.08 vs 1.89 ± 2.40; P = .009), and blood C-reactive protein (CRP) levels after 48 hours (69.0 vs 18.58 mg/dL; P = .045) and 1 week (113.50 vs 5.16 mg/dL; P = .004) were significantly higher in cases of CGD.Conclusions
CGD is a rare reaction that might be triggered by prostatic zonal anatomy, embolization technique, and mechanical or inflammatory processes. It should be considered in patients with severe postoperative pain and high CRP levels who experience voiding dysfunction after PAE to avoid complications. Investigation of larger cohorts might further elucidate this tissue response. 相似文献5.
6.
Judith Brock Andreas Schmid Thomas Karrasch Petra Pfefferle Jutta Schlegel Inga Busse Annette Hauenschild Barbara Schmidt Maria Koukou Efthymia Arapogianni Andreas Schultz Miriam Thomalla Secil Akinci Johannes Kruse Winfried Padberg Andreas Schffler Jens Albrecht 《Clinical endocrinology》2019,91(3):400-410
7.
8.
Johannes Poms Stephan Sacher Matthias Nixdorf Michael Dekner Sabine Wallner-Mang Ines Janssen 《Pharmaceutical development and technology》2019,24(6):739-750
An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided. 相似文献
9.
10.
Julie A. Schmidt Georgina K. Fensom Sabina Rinaldi Augustin Scalbert Paul N. Appleby David Achaintre Audrey Gicquiau Marc J. Gunter Pietro Ferrari Rudolf Kaaks Tilman Kühn Heiner Boeing Antonia Trichopoulou Anna Karakatsani Eleni Peppa Domenico Palli Sabina Sieri Rosario Tumino Bas Bueno-de-Mesquita Antonio Agudo Maria-Jose Sánchez María-Dolores Chirlaque Eva Ardanaz Nerea Larrañaga Aurora Perez-Cornago Nada Assi Elio Riboli Konstantinos K. Tsilidis Timothy J. Key Ruth C. Travis 《International journal of cancer. Journal international du cancer》2020,146(3):720-730
Metabolomics may reveal novel insights into the etiology of prostate cancer, for which few risk factors are established. We investigated the association between patterns in baseline plasma metabolite profile and subsequent prostate cancer risk, using data from 3,057 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition (EPIC). We measured 119 metabolite concentrations in plasma samples, collected on average 9.4 years before diagnosis, by mass spectrometry (AbsoluteIDQ p180 Kit, Biocrates Life Sciences AG). Metabolite patterns were identified using treelet transform, a statistical method for identification of groups of correlated metabolites. Associations of metabolite patterns with prostate cancer risk (OR1SD) were estimated by conditional logistic regression. Supplementary analyses were conducted for metabolite patterns derived using principal component analysis and for individual metabolites. Men with metabolite profiles characterized by higher concentrations of either phosphatidylcholines or hydroxysphingomyelins (OR1SD = 0.77, 95% confidence interval 0.66–0.89), acylcarnitines C18:1 and C18:2, glutamate, ornithine and taurine (OR1SD = 0.72, 0.57–0.90), or lysophosphatidylcholines (OR1SD = 0.81, 0.69–0.95) had lower risk of advanced stage prostate cancer at diagnosis, with no evidence of heterogeneity by follow-up time. Similar associations were observed for the two former patterns with aggressive disease risk (the more aggressive subset of advanced stage), while the latter pattern was inversely related to risk of prostate cancer death (OR1SD = 0.77, 0.61–0.96). No associations were observed for prostate cancer overall or less aggressive tumor subtypes. In conclusion, metabolite patterns may be related to lower risk of more aggressive prostate tumors and prostate cancer death, and might be relevant to etiology of advanced stage prostate cancer. 相似文献